文献速递功能神经外科

接受脑深部电刺激植入的帕金森病患者影像学异常及其临床意义

Radiographic abnormalities and their clinical significance in patients with Parkinson disease who receive deep brain stimulation implants.
PubMed 文献 · J Neurosurg · 2024-07-19

本研究回顾性分析了2010至2022年在本机构因脑深部电刺激电极植入而行MRI的帕金森病患者,识别术前影像学异常并分组,评估其与1年及末次随访临床结局的相关性。结果显示大多数影像学异常对临床结局无显著影响,但萎缩或退行性改变可能与较差的主观临床反应相关。

要点

  • 160例患者中135例存在至少1种影像学异常,以缺血性血管改变最常见(69.4%)。
  • 影像学异常组与无异常组在1年及末次随访的结局无显著差异。
  • 萎缩或退行性改变与1年及末次随访较差的主观临床反应相关,但与客观指标无关。

核心结论

  • 大多数影像学异常对接受脑深部电刺激的帕金森病患者临床结局无显著影响。
  • 广泛的萎缩或退行性改变可能与较差的主观反应相关,若术前MRI诊断则可能与患者进一步讨论。

研究设计与样本

  • 回顾性审查本机构2010年至2022年因脑深部电刺激电极植入而行MRI的帕金森病患者记录,从官方术前MRI报告中识别影像学异常,分为缺血性改变、萎缩或退行性改变、结构异常和肿瘤四类,并与1年及末次随访的临床结局进行相关性分析。
  • 初始分析纳入160例患者。

主要发现

  • 135例患者存在至少1种影像学异常,其中缺血性血管改变占69.4%(111/160),萎缩或退行性改变占39.4%(63/160),结构改变占16.9%(27/160),肿瘤占1.9%(3/160)。
  • 各组间术前左旋多巴等效剂量或UPDRS评分无差异。
  • 脑深部电刺激术后,影像学异常组与无异常组在1年及末次随访的结局无差异,包括死亡率及死亡时间。
  • 结构病变与较低死亡率相关(OR 0.1,p=0.04)。
  • 萎缩或退行性改变与1年(OR 0.50,p=0.04)及末次随访(OR 0.49,p=0.03)较差的主观临床反应相关,但主观较差反应与较差的客观结局指标无关。

临床怎么用

  • 作者认为,大多数影像学异常对接受脑深部电刺激的帕金森病患者临床结局无显著影响。
  • 作者认为,广泛的萎缩或退行性改变可能与较差的主观反应相关,若术前MRI诊断则可能与患者进一步讨论。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Preoperative MR images obtained in patients with Parkinson disease (PD) undergoing deep brain stimulation (DBS) often reveal incidental radiographic abnormalities (RAs). These findings range from small changes to gross pathologies. The effect of these findings on patients' clinical outcomes is unknown. The authors characterized RAs in patients with PD who underwent DBS and assessed clinical outcomes. METHODS: Records of patients at the authors' institution with PD who underwent MRI for DBS electrode implantation from 2010 through 2022 were reviewed. RAs were identified from the official preoperative MRI reports. RAs were grouped into four general categories (ischemic changes, atrophy or degenerative changes [ADCs], structural abnormalities, and tumors) and correlated with clinical outcomes (including subjective clinical response, levodopa equivalent dose [LED], and Unified Parkinson's Disease Rating Scale Part III [UPDRS] score) at the 1-year and last available follow-ups. RESULTS: In this review, 160 patients were identified for initial analysis, with 135 presenting with ≥ 1 RAs. Of these 135 patients, 69.4% (111/160) had ischemic vascular changes, 39.4% (63/160) had ADCs, 16.9% (27/160) had structural changes, and 1.9% (3/160) had tumors. No differences in preoperative LED or UPDRS score were observed between these groups. After DBS, no differences in outcomes were observed between patients with RAs and those without RAs for both the 1-year and last follow-up time points, including mortality rates and times. Structural lesions were associated with lower mortality rates (OR 0.1, p = 0.04). ADCs were associated with a worse subjective clinical response at the 1-year (OR 0.50, p = 0.04) and last (OR 0.49, p = 0.03) follow-ups, but subjectively worse responses were not correlated with worse objective outcome measures. CONCLUSIONS: Most RAs have no significant effect on clinical outcomes in PD patients undergoing DBS. Generalized ADCs may be associated with poorer subjective responses and may warrant further discussion with the patient if diagnosed on preoperative MRI.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Findlay MC, Tenhoeve SA, Campbell JM, et al. Radiographic abnormalities and their clinical significance in patients with Parkinson disease who receive deep brain stimulation implants. J Neurosurg. 2024. PMID: 39029131. doi:10.3171/2024.4.JNS24365

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。